1. Maehara Y, Tsujitani S, Saeki H, et al. Biological mechanism and clinical effect of protein-bound polysaccharide K (KRESTIN((R))): review of development and future perspectives. Surg Today. 2012;42:8–28.
2. Tanaka H, Muguruma K, Ohira M, et al. Impact of adjuvant immunochemotherapy using protein-bound polysaccharide-K on overall survival of patients with gastric cancer. Anticancer Res. 2012;32:3427–33.
3. Ohashi Y, Watanabe M, Ikeda M, et al. Regression of metastatic hepatic cancer from gastric cancer by polysaccharide K and UFT administration—a case report. Gan To Kagaku Ryoho. 2008;35:2409–12.
4. Choi JH, Kim YB, Lim HY, et al. 5-Fluorouracil, mitomycin-C, and polysaccharide-K adjuvant chemoimmunotherapy for locally advanced gastric cancer: the prognostic significance of frequent perineural invasion. Hepatogastroenterology. 2007;54:290–7.
5. Hirahara N, Edamatsu T, Fujieda A, Fujioka M, Wada T, Tajima Y. Protein-bound polysaccharide-K (PSK) induces apoptosis via p38 mitogen-activated protein kinase pathway in promyelomonocytic leukemia HL-60 cells. Anticancer Res. 2012;32:2631–7.